Skip to search formSkip to main contentSkip to account menu

AB103

Known as: AB103 peptide, SPMLVAYD, p2TA peptide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BACKGROUND Necrotizing soft tissue infections (NSTIs) are severe and rapidly spreading soft tissue infections of the subcutaneous… 
2015
2015
Non-obstructive azoospermia (NOA), a severe form of male infertility, is often suspected to be linked to currently undefined… 
2015
2015
BACKGROUND Severe gram-negative bacterial infections and sepsis are major causes of morbidity and mortality. Dysregulated… 
Highly Cited
2014
Highly Cited
2014
IMPORTANCE Necrotizing soft-tissue infections (NSTI) have high morbidity and mortality rates despite aggressive surgical… 
2014
2014
The goal of this study was to elucidate the action of the CD28 mimetic peptide p2TA (AB103) that attenuates an excessive… 
2014
2014
Thearticle byBulger et al1 represents an advance in theworld of surgical infections as the first interventional trial using an… 
Review
2014
Review
2014
Objective To compare the survival effect between radical prostatectomy (RP) and active surveillance (AS) for the treatment of… 
2013
2013
Staphylococcus aureus and group A Streptococcus pyogenes (GAS) express superantigen (SAg) exotoxin proteins capable of inducing… 
2011
2011
AB103 is a novel CD28 antagonist peptide currently in clinical development that modulates CD28 signaling in T cells, without… 
1990
1990
A model was formulated to examine specific experimental data of growth and heterologous product formation with recombinant…